Prostaglandin E2

Prostaglandin E2 is a lipid of Fatty Acyls (FA) class. Prostaglandin e2 is associated with abnormalities such as Renal glomerular disease, Arthritis, Degenerative polyarthritis, Pancreatitis and Rheumatoid Arthritis. The involved functions are known as enzyme pathway, Atherogenesis, Anabolism, inhibitors and Oxidants. Prostaglandin e2 often locates in Tissue membrane, Blood, Extracellular, Membrane and Protoplasm. The associated genes with Prostaglandin E2 are PTGS2 gene, TP53 gene, TNFRSF5 gene, FASTK Gene and TNF gene. The related lipids are Lipopolysaccharides, Steroids, monooxyethylene trimethylolpropane tristearate, Fatty Acids, Unsaturated and Promega. The related experimental models are Arthritis, Adjuvant-Induced, Xenograft Model, Experimental Autoimmune Encephalomyelitis, Cancer Model and Knock-out.

Cross Reference

Introduction

To understand associated biological information of Prostaglandin E2, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Prostaglandin E2?

Prostaglandin E2 is suspected in Asthma, Inflammatory disorder, Arthritis, Obesity, Renal tubular disorder, Ischemia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Prostaglandin E2

MeSH term MeSH ID Detail
Airway Obstruction D000402 13 associated lipids
Uremia D014511 33 associated lipids
Colitis, Ulcerative D003093 24 associated lipids
Stomach Ulcer D013276 75 associated lipids
Kidney Failure, Chronic D007676 51 associated lipids
Diarrhea D003967 32 associated lipids
Hypoxia D000860 23 associated lipids
Hypercalcemia D006934 13 associated lipids
Neovascularization, Pathologic D009389 39 associated lipids
Adenocarcinoma D000230 166 associated lipids
Per page 10 20 50 100 | Total 351

PubChem Associated disorders and diseases

What pathways are associated with Prostaglandin E2

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Prostaglandin E2?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Prostaglandin E2?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Prostaglandin E2?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Prostaglandin E2?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Prostaglandin E2?

Arthritis, Collagen-Induced

Arthritis, Collagen-Induced are used in the study 'Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling.' (Boniface K et al., 2009), Arthritis, Collagen-Induced are used in the study 'Perspective of microsomal prostaglandin E2 synthase-1 as drug target in inflammation-related disorders.' (Koeberle A and Werz O, 2015), Arthritis, Collagen-Induced are used in the study 'Prostaglandin receptor EP2 in the crosshairs of anti-inflammation, anti-cancer, and neuroprotection.' (Jiang J and Dingledine R, 2013), Arthritis, Collagen-Induced are used in the study 'Comparison of the efficacy and skin permeability of topical NSAID preparations used in Europe.' (Komatsu T and Sakurada T, 2012) and Arthritis, Collagen-Induced are used in the study 'Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.' (Pawlik M et al., 2011).

Arthritis, Adjuvant-Induced

Arthritis, Adjuvant-Induced are used in the study 'Comparison of the efficacy and skin permeability of topical NSAID preparations used in Europe.' (Komatsu T and Sakurada T, 2012), Arthritis, Adjuvant-Induced are used in the study 'A pure polysaccharide from Ephedra sinica treating on arthritis and inhibiting cytokines expression.' (Wang Q et al., 2016) and Arthritis, Adjuvant-Induced are used in the study 'Prostaglandin E2 activates Rap1 via EP2/EP4 receptors and cAMP-signaling in rheumatoid synovial fibroblasts: involvement of Epac1 and PKA.' (Kojima F et al., 2009).

Experimental Autoimmune Encephalomyelitis

Experimental Autoimmune Encephalomyelitis are used in the study 'Ginsenoside Rb1 prevents interleukin-1 beta induced inflammation and apoptosis in human articular chondrocytes.' (Cheng W et al., 2013), Experimental Autoimmune Encephalomyelitis are used in the study 'PGE2/EP4 signaling in peripheral immune cells promotes development of experimental autoimmune encephalomyelitis.' (Schiffmann S et al., 2014) and Experimental Autoimmune Encephalomyelitis are used in the study 'Concurrent blockade of free radical and microsomal prostaglandin E synthase-1-mediated PGE2 production improves safety and efficacy in a mouse model of amyotrophic lateral sclerosis.' (Shin JH et al., 2012).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Prostaglandin E2

Download all related citations
Per page 10 20 50 100 | Total 24543
Authors Title Published Journal PubMed Link
pmid:
Koolpe M et al. Expression of both P1 and P2 purine receptor genes by human articular chondrocytes and profile of ligand-mediated prostaglandin E2 release. 1999 Arthritis Rheum. pmid:10025919
Ingram JN et al. Cortisol in fetal fluids and the fetal adrenal at parturition in the tammar wallaby (Macropus eugenii). 1999 Biol. Reprod. pmid:10026112
Xiao CW et al. Down-regulation of oxytocin-induced cyclooxygenase-2 and prostaglandin F synthase expression by interferon-tau in bovine endometrial cells. 1999 Biol. Reprod. pmid:10026113
Baguma-Nibasheka M et al. Delay of preterm delivery in sheep by omega-3 long-chain polyunsaturates. 1999 Biol. Reprod. pmid:10026118
Saunders MA et al. Mechanisms of prostaglandin E2 release by intact cells expressing cyclooxygenase-2: evidence for a 'two-component' model. 1999 J. Pharmacol. Exp. Ther. pmid:10027847
Van de Weerdt ML et al. Ketoprofen and phenylbutazone attenuation of PAF-induced lung inflammation in calves. 1999 Vet. J. pmid:10030127
Boyle JE et al. Prostaglandin-E2 counteracts interleukin-1beta-stimulated upregulation of platelet-derived growth factor alpha-receptor on rat pulmonary myofibroblasts. 1999 Am. J. Respir. Cell Mol. Biol. pmid:10030841
Hirst WD et al. Expression of COX-2 by normal and reactive astrocytes in the adult rat central nervous system. 1999 Mol. Cell. Neurosci. pmid:10049531
Gan L et al. A new computerized biomechanical perfusion model for ex vivo study of fluid mechanical forces in intact conduit vessels. J. Vasc. Res. pmid:10050075
Rouaud C et al. The cyclo-oxygenase-dependent regulation of rabbit vein contraction: evidence for a prostaglandin E2-mediated relaxation. 1999 Br. J. Pharmacol. pmid:10051118
Cunha FQ et al. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4. 1999 Br. J. Pharmacol. pmid:10051119
Hamilton SG et al. The effects of inflammation and inflammatory mediators on nociceptive behaviour induced by ATP analogues in the rat. 1999 Br. J. Pharmacol. pmid:10051152
Bastepe M and Ashby B Identification of a region of the C-terminal domain involved in short-term desensitization of the prostaglandin EP4 receptor. 1999 Br. J. Pharmacol. pmid:10051157
pmid:10051237
Roland CR et al. Gadolinium blocks rat Kupffer cell calcium channels: relevance to calcium-dependent prostaglandin E2 synthesis and septic mortality. 1999 Hepatology pmid:10051477
Fitzgerald J and Hughes-Fulford M Mechanically induced c-fos expression is mediated by cAMP in MC3T3-E1 osteoblasts. 1999 FASEB J. pmid:10064622
Yucel-Lindberg T et al. Signal transduction pathways involved in the synergistic stimulation of prostaglandin production by interleukin-1beta and tumor necrosis factor alpha in human gingival fibroblasts. 1999 J. Dent. Res. pmid:10065947
Watson CS et al. Prostaglandin E2 inhibition of fetal breathing movements is not sustained during prolonged reduced uterine blood flow in sheep. 1998 Can. J. Physiol. Pharmacol. pmid:10066135
Goddard PJ et al. HCO3-secretion by bullfrog duodenum: dependence on nutrient Na+ during secretory stimulation. 1998 Can. J. Physiol. Pharmacol. pmid:10066138
Aley KO and Levine JD Role of protein kinase A in the maintenance of inflammatory pain. 1999 J. Neurosci. pmid:10066271
Langberg H et al. Metabolism and inflammatory mediators in the peritendinous space measured by microdialysis during intermittent isometric exercise in humans. 1999 J. Physiol. (Lond.) pmid:10066916
Evans AR et al. The cAMP transduction cascade mediates the PGE2-induced inhibition of potassium currents in rat sensory neurones. 1999 J. Physiol. (Lond.) pmid:10066931
Amano K et al. Elective induction of labor at 39 weeks of gestation: a prospective randomized trial. 1999 J. Obstet. Gynaecol. Res. pmid:10067011
Miner TJ et al. Ischemia-reperfusion protects the rat small intestine against subsequent injury. 1999 J. Surg. Res. pmid:10068518
Hisakawa N et al. Down regulation by iron of prostaglandin E2 production by human synovial fibroblasts. 1998 Ann. Rheum. Dis. pmid:10070275
Takahashi H et al. Ureteral obstruction reverses glomerular proliferation in immune complex glomerulonephritis. 1999 J. Lab. Clin. Med. pmid:10072261
Bao JF et al. Effect of sodium glycyrrhetinate on chemical peritonitis in rats. 1997 Zhongguo Yao Li Xue Bao pmid:10072951
Dean DD et al. Ultrahigh molecular weight polyethylene particles have direct effects on proliferation, differentiation, and local factor production of MG63 osteoblast-like cells. 1999 J. Orthop. Res. pmid:10073642
Dinarello CA et al. Fever: links with an ancient receptor. 1999 Curr. Biol. pmid:10074418
Kwiatkowski P et al. High-level porcine endothelial cell expression of alpha(1,2)-fucosyltransferase reduces human monocyte adhesion and activation. 1999 Transplantation pmid:10075584
Scholtka B et al. Acute increase, stimulated by prostaglandin E2, in glucose absorption via the sodium dependent glucose transporter-1 in rat intestine. 1999 Gut pmid:10075955
Denison FC et al. The action of prostaglandin E2 on the human cervix: stimulation of interleukin 8 and inhibition of secretory leukocyte protease inhibitor. 1999 Am. J. Obstet. Gynecol. pmid:10076137
Derman SG et al. Transforming growth factor-beta1 is a potent inhibitor of interleukin-1beta action in whole ovarian dispersates. 1999 J. Endocrinol. pmid:10076187
Hua XY et al. Intrathecal substance P-induced thermal hyperalgesia and spinal release of prostaglandin E2 and amino acids. 1999 Neuroscience pmid:10077333
Denis D and Riendeau D Phosphodiesterase 4-dependent regulation of cyclic AMP levels and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes. 1999 Eur. J. Pharmacol. pmid:10079010
Kokubu T et al. Low intensity pulsed ultrasound exposure increases prostaglandin E2 production via the induction of cyclooxygenase-2 mRNA in mouse osteoblasts. 1999 Biochem. Biophys. Res. Commun. pmid:10079177
Nakamoto H et al. Effects of cicletanine on the progression of renal failure in 5/6 nephrectomized hypertensive rats. 1999 Clin. Exp. Pharmacol. Physiol. pmid:10081620
Ota S et al. Nonsteroidal anti-inflammatory drugs may prevent colon cancer through suppression of hepatocyte growth factor expression. 1999 Eur. J. Pharmacol. pmid:10082276
Yasuda T et al. The novel analgesic compound OT-7100 (5-n-butyl-7-(3,4,5-trimethoxybenzoylamino)pyrazolo[1,5-a]pyrimid ine) attenuates mechanical nociceptive responses in animal models of acute and peripheral neuropathic hyperalgesia. 1999 Jpn. J. Pharmacol. pmid:10082319
McCracken BA et al. Weaning anorexia may contribute to local inflammation in the piglet small intestine. 1999 J. Nutr. pmid:10082764
Pestana M et al. Kidney graft-infiltrating cells synthesize significantly higher amounts of prostaglandin E2 pre and during acute rejection. 1999 Feb-Mar Transplant. Proc. pmid:10083119
van den Dorpel MA et al. Beneficial effects of conversion from cyclosporine to azathioprine on fibrinolysis in renal transplant recipients. 1999 Feb-Mar Transplant. Proc. pmid:10083130
Blaheta RA et al. Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells. Transplant. Proc. pmid:10083559
pmid:10084948
Chen X and Levine JD NOS inhibitor antagonism of PGE2-induced mechanical sensitization of cutaneous C-fiber nociceptors in the rat. 1999 J. Neurophysiol. pmid:10085324
Cocks TM et al. A protective role for protease-activated receptors in the airways. 1999 Nature pmid:10086357
Garcia-Pastor P et al. Effects of petrosaspongiolide M, a novel phospholipase A2 inhibitor, on acute and chronic inflammation. 1999 J. Pharmacol. Exp. Ther. pmid:10087000
Avella M et al. Regulation of Cl- secretion in seawater fish (Dicentrarchus labrax) gill respiratory cells in primary culture. 1999 J. Physiol. (Lond.) pmid:10087336
Kolenko V et al. Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signaling pathway. 1999 Blood pmid:10090941
Díaz-Cazorla M et al. Regulation of cyclooxygenase-2 expression in human mesangial cells--transcriptional inhibition by IL-13. 1999 Eur. J. Biochem. pmid:10091607
Attur MG et al. Tetracycline up-regulates COX-2 expression and prostaglandin E2 production independent of its effect on nitric oxide. 1999 J. Immunol. pmid:10092766
Shoda J et al. Secretory low-molecular-weight phospholipases A2 and their specific receptor in bile ducts of patients with intrahepatic calculi: factors of chronic proliferative cholangitis. 1999 Hepatology pmid:10094942
Ehrich EW et al. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. 1999 Clin. Pharmacol. Ther. pmid:10096266
Wani MR et al. Prostaglandin E2 cooperates with TRANCE in osteoclast induction from hemopoietic precursors: synergistic activation of differentiation, cell spreading, and fusion. 1999 Endocrinology pmid:10098533
Keles I et al. The effects of bovine respiratory syncytial on normal ovine lymphocyte responses to mitogens or antigens in vitro. 1999 Comp. Immunol. Microbiol. Infect. Dis. pmid:10099024
Lay JC et al. Cellular and biochemical response of the human lung after intrapulmonary instillation of ferric oxide particles. 1999 Am. J. Respir. Cell Mol. Biol. pmid:10100994
Fernández de Arriba A et al. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid. 1999 Mol. Pharmacol. pmid:10101034
Wentzel P et al. Developmental damage, increased lipid peroxidation, diminished cyclooxygenase-2 gene expression, and lowered prostaglandin E2 levels in rat embryos exposed to a diabetic environment. 1999 Diabetes pmid:10102698
Messager S et al. Long-term exposure of hypothalamic explants to melatonin alters the release of gonadotrophin releasing hormone and the density of melatonin binding sites in the pars tuberalis of the male mink (Mustela vison). 1999 J. Pineal Res. pmid:10102756
Cole AT et al. Protection of human gastric mucosa against aspirin-enteric coating or dose reduction? 1999 Aliment. Pharmacol. Ther. pmid:10102949
Hass SL and Lucas MJ Net economic benefit of a manufactured dinoprostone gel for pre-induction cervical ripening. 1994 Pharmacoeconomics pmid:10146865
Taylor SJ and Armour CL Cost implications in the management of induction of labour. 1997 Pharmacoeconomics pmid:10174321
Xing M et al. Inhibition of phospholipase A2-mediated arachidonic acid release by cyclic AMP defines a negative feedback loop for P2Y receptor activation in Madin-Darby canine kidney D1 cells. 1999 J. Biol. Chem. pmid:10187781
Brambilla R et al. Cyclo-oxygenase-2 mediates P2Y receptor-induced reactive astrogliosis. 1999 Br. J. Pharmacol. pmid:10188963
Poole S et al. Bradykinin B1 and B2 receptors, tumour necrosis factor alpha and inflammatory hyperalgesia. 1999 Br. J. Pharmacol. pmid:10188975
ACOG committee opinion. Monitoring during induction of labor with dinoprostone. Number 209, October 1998. Committee on Obstetric Practice. American College of Obstetricians and Gynecologists. 1999 Int J Gynaecol Obstet pmid:10189036
Xie X et al. Influence of local haemodynamics on leucocyte rolling and chemoattractant-induced firm adhesion in microvessels of the rat mesentery. 1999 Acta Physiol. Scand. pmid:10192173
pmid:10193662
Brideau C et al. The effects of phosphodiesterase type 4 inhibitors on tumour necrosis factor-alpha and leukotriene B4 in a novel human whole blood assay. 1999 Br. J. Pharmacol. pmid:10193778
Aarab L et al. Cell-specific coupling of PGE2 to different transduction pathways in arginine vasopressin- and glucagon-sensitive segments of the rat renal tubule. 1999 Br. J. Pharmacol. pmid:10193786
Offenbacher S and Salvi GE Induction of prostaglandin release from macrophages by bacterial endotoxin. 1999 Clin. Infect. Dis. pmid:10194068
Watson CS et al. Increased cerebral extracellular adenosine and decreased PGE2 during ethanol-induced inhibition of FBM. 1999 J. Appl. Physiol. pmid:10194230
Celebioglu B et al. The effect of tenoxicam on intraperitoneal adhesions and prostaglandin E2 levels in mice. 1999 Anesth. Analg. pmid:10195553
Sawdy RJ et al. Region and labour-dependent synthesis of prostaglandin E2 by human fetal membranes. Placenta pmid:10195739
Howe LR et al. Transcriptional activation of cyclooxygenase-2 in Wnt-1-transformed mouse mammary epithelial cells. 1999 Cancer Res. pmid:10197631
Song Y et al. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 1. Thiazolone and oxazolone series. 1999 J. Med. Chem. pmid:10197959
Song Y et al. Synthesis, structure-activity relationships, and in vivo evaluations of substituted di-tert-butylphenols as a novel class of potent, selective, and orally active cyclooxygenase-2 inhibitors. 2. 1,3,4- and 1,2,4-thiadiazole series. 1999 J. Med. Chem. pmid:10197960
Zhou H and Tai HH Threonine 188 is critical for interaction with NAD+ in human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase. 1999 Biochem. Biophys. Res. Commun. pmid:10198228
Yucel-Lindberg T et al. Involvement of tyrosine kinases on cyclooxygenase expression and prostaglandin E2 production in human gingival fibroblasts stimulated with interleukin-1beta and epidermal growth factor. 1999 Biochem. Biophys. Res. Commun. pmid:10198245
Nakagawa T et al. Interleukin-1 alpha induced cyclooxygenase-2 expression in bone-derived endothelial cells. 1999 J. Cell. Physiol. pmid:10199562
Ebersberger A et al. Release of substance P, calcitonin gene-related peptide and prostaglandin E2 from rat dura mater encephali following electrical and chemical stimulation in vitro. 1999 Neuroscience pmid:10199623
Petraglia F et al. Urocortin stimulates placental adrenocorticotropin and prostaglandin release and myometrial contractility in vitro. 1999 J. Clin. Endocrinol. Metab. pmid:10199789
Patel R et al. Regulation of cytosolic COX-2 and prostaglandin E2 production by nitric oxide in activated murine macrophages. 1999 J. Immunol. pmid:10201946
Marshall JS et al. Nerve growth factor modifies the expression of inflammatory cytokines by mast cells via a prostanoid-dependent mechanism. 1999 J. Immunol. pmid:10201958
Onoe H [Molecular and neuroanatomical mechanisms of sleep-wakefulness regulation by prostaglandins D2 and E2]. 1998 Nippon Yakurigaku Zasshi pmid:10202759
Bateson EA et al. Response of fetal rabbit ductus arteriosus to bradykinin: role of nitric oxide, prostaglandins, and bradykinin receptors. 1999 Pediatr. Res. pmid:10203150
Kitamura Y et al. Activators of peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells. 1999 Neurosci. Lett. pmid:10203248
Nelson DM et al. Hypoxia limits differentiation and up-regulates expression and activity of prostaglandin H synthase 2 in cultured trophoblast from term human placenta. 1999 Am. J. Obstet. Gynecol. pmid:10203658
Carruthers AM et al. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins. 1999 Br. J. Pharmacol. pmid:10205012
Vause S and Macintosh M Evidence based case report: use of prostaglandins to induce labour in women with a caesarean section scar. 1999 BMJ pmid:10205107
Brock TG et al. Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2. 1999 J. Biol. Chem. pmid:10206978
Barnes CJ et al. Effect of aspirin on prostaglandin E2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon. 1999 Cancer Epidemiol. Biomarkers Prev. pmid:10207634
Iwasaki K et al. Prostaglandin E2 and I2 regulate intercellular adhesion molecule-1 expression in interleukin-1 beta-stimulated human gingival fibroblasts. 1999 J. Periodont. Res. pmid:10207838
Nagai M and Sato N Reciprocal gene expression of osteoclastogenesis inhibitory factor and osteoclast differentiation factor regulates osteoclast formation. 1999 Biochem. Biophys. Res. Commun. pmid:10208850
Fleisher-Berkovich S and Danon A IL-1alpha but not IL-1beta-induced prostaglandin synthesis is inhibited by corticotropin-releasing factor. 1999 Cytokine pmid:10209072
Alaaeddine N et al. Inhibition of tumor necrosis factor alpha-induced prostaglandin E2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: distinct targeting in the signaling pathways. 1999 Arthritis Rheum. pmid:10211885
Homaidan FR et al. Morphological and functional changes in the colonic epithelial cells in a rabbit model of colitis. 1999 Inflammation pmid:10213274
Kästner SB et al. Investigations on the ability of clenbuterol hydrochloride to reduce clinical signs and inflammation associated with equine influenza A infection. 1999 Equine Vet. J. pmid:10213429
Schepelmann K et al. Response properties of trigeminal brain stem neurons with input from dura mater encephali in the rat. 1999 Neuroscience pmid:10215158